NEMAURA - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79185414
Serial Number
79185414
Registration Number
5293350
Word Mark
NEMAURA
Status
700 - Registered
Status Date
2017-09-26
Filing Date
2015-12-24
Registration Number
5293350
Registration Date
2017-09-26
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2017-07-11
Attorney Name
Law Office Assigned Location Code
N20
Employee Name
ROSENBLATT, ANNA HASSE
Statements
Goods and Services
Pharmaceutical and veterinary preparations for treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Sanitary preparations for medical purposes; Diagnostic preparations and substances for medical or veterinary purposes; Medical diagnostic reagents; Antiserums for medical or veterinary diagnostic purposes; Vaccines for human beings and animals; Adjuvants for use with vaccines; Biological laboratory preparations for medical and veterinary purposes for the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Chemical preparations and reagents for medical, pharmaceutical and veterinary purposes for the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Viruses for the treatment of humans and animals for the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Diagnostic preparations for medical purposes; In-vitro diagnostics for medical purposes; In-vivo diagnostics for medical purposes; Medical plasters; Transdermal patches for use in the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Transdermal plasters for use in the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Transdermal therapeutic drug delivery systems (TTS), namely, transdermal patches and plasters treated or impregnated with pharmaceutical active ingredients for the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Medicated transdermal drug delivery patches featuring medication for the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Vaccines; Drug delivery agents in the form of dissolvable films, coatings for tablets, capsules that facilitate the delivery of pharmaceutical preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations for injection in the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Drug delivery agents in the form of liquid medications, tablets, powders, capsules, inhalants, nasal sprays, orally disintegrating tablets, and mouthwashes that facilitate the delivery of pharmaceutical preparations; Balms for medical purposes; Tonics for medical purposes, namely, for the treatment of diabetes, cardiovascular conditions, pulmonary conditions, skin conditions, infectious diseases, central nervous system disorders, metabolic disorders, cancer, and chronic pain; Disinfectants, antiseptics
Goods and Services
Surgical apparatus and instruments for medical, dental or veterinary use; Suture materials; Inhalers for medical purposes; Filters for inhalers for medical purposes; Inhalers for medical use; Inhalers for therapeutic use; Electromagnetic drug delivery apparatus for medical use; Drug delivery apparatus and devices, namely, medical apparatus and units for dosage, measuring and monitoring; Microneedle arrays for delivering medications; Hypodermic syringes for injections for medical purposes; Electrical drug delivery apparatus for medical use; Needles for medical and surgical use; Hypodermic needles
Goods and Services
Medical research services; Conducting clinical trials for others; Medical research laboratory services; Medical research laboratory services for the analysis of samples taken from patients; Scientific analysis and research services, namely, DNA analysis services for scientific research purposes; Product development relating to pharmaceuticals, medicines, medicaments and veterinary products; Medical and health care testing services for research purposes, namely, clinical testing services, physician testing services for assisting pharmacists, pharmaceutical testing services, and medical laboratory and testing services; Pharmaceutical research and development services; Medical and scientific research information in the field of healthcare; Cosmetics research; Design and development of computer hardware and software and information storage retrieval services in the fields of diagnostic testing and preparations for the treatment, monitoring or diagnosis of disease
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2016-04-01
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2016-04-01
Primary Code
010
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2016-04-01
Primary Code
042
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
DAVID A.W. WONG
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1294203
International Registration Date
2015-12-24
International Publication Date
2016-03-31
International Renewal Date
2025-12-24
Auto Protection Date
2017-09-30
International Status
001 - Request for extension of protection established
International Status Date
2016-03-31
Priority Claimed In
True
Priority Claimed Date
2015-07-13
First Refusal In
True
Trademark Events
Event DateEvent Description
2016-03-31SN ASSIGNED FOR SECT 66A APPL FROM IB
2016-04-01NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2016-04-05APPLICATION FILING RECEIPT MAILED
2016-04-11ASSIGNED TO EXAMINER
2016-04-21NON-FINAL ACTION WRITTEN
2016-04-22NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2016-04-22REFUSAL PROCESSED BY MPU
2016-04-22NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2016-05-14REFUSAL PROCESSED BY IB
2016-10-21TEAS RESPONSE TO OFFICE ACTION RECEIVED
2016-10-21CORRESPONDENCE RECEIVED IN LAW OFFICE
2016-10-21TEAS/EMAIL CORRESPONDENCE ENTERED
2016-11-14FINAL REFUSAL WRITTEN
2016-11-14FINAL REFUSAL E-MAILED
2016-11-14NOTIFICATION OF FINAL REFUSAL EMAILED
2017-02-02CHANGE OF NAME/ADDRESS REC'D FROM IB
2017-05-15EXPARTE APPEAL RECEIVED AT TTAB
2017-05-15JURISDICTION RESTORED TO EXAMINING ATTORNEY
2017-05-15EX PARTE APPEAL-INSTITUTED
2017-05-15TEAS REQUEST FOR RECONSIDERATION RECEIVED
2017-05-31EXAMINERS AMENDMENT -WRITTEN
2017-05-31EXAMINERS AMENDMENT E-MAILED
2017-05-31NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2017-05-31EXAMINER'S AMENDMENT ENTERED
2017-05-31APPROVED FOR PUB - PRINCIPAL REGISTER
2017-05-31EXPARTE APPEAL TERMINATED
2017-06-21NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-06-21NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2017-06-21NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2017-07-08NOTIFICATION PROCESSED BY IB
2017-07-11PUBLISHED FOR OPPOSITION
2017-07-11OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-08-30NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
2017-08-30NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2017-09-15NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
2017-09-26REGISTERED-PRINCIPAL REGISTER
2017-12-01NEW REPRESENTATIVE AT IB RECEIVED
2017-12-26FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2018-01-12FINAL DISPOSITION PROCESSED
2018-01-12FINAL DISPOSITION NOTICE SENT TO IB
2018-02-10FINAL DECISION TRANSACTION PROCESSED BY IB